Rivastigmine Market Poised for Growth Due to Rising Adoption of Novel Drug Delivery Systems Rivastigmine is primarily used in the treatment of mild to moderate Alzheimer's disease and Parkinson's disease dementia symptoms. It helps in improving the symptoms of mental decline by inhibiting the breakdown of acetylcholine, a chemical messenger important for thinking, learning, and memory. The drug is administered orally through capsules or transdermal patches for continuous delivery into...
0 Shares
482 Views
0 Reviews